INTRODUCTION
Matrix attachment regions (MARs) comprise discrete DNA segments dispersed throughout the metazoan genome. MARs are operationally defined as DNA sequences that are retained on the nuclear scaffold after chromatin has been selectively depleted of histones by salt extractions (1) . Although welldefined structurally and biochemically (2,3 and references therein) the in vivo function(s) of MARs in gene expression remain to be clearly identified and tested.
MARs are postulated to serve a variety of functions in gene expression. The periodic attachment of chromatin to the nuclear scaffold may organize chromatin within the nucleus (1, 4) and sequester local cis-acting DNA elements within specific and functionally defined nuclear subregions. Indeed, the association of RNA polymerase II with the nuclear matrix suggests that transcription itself occurs in association with these structures (2,5, reviewed in 6,7). MARs have been shown to insulate reporter transgenes from position effects (8) as well as to augment the activity of enhancer elements by extending the distance over which they can function (9, 10) . The latter activity has been linked to specific extension of DNA demethylation (9) and chromatin core histone acetylation (11, 12) from MAR-associated enhancers to target promoters. As such, MARs are thought to subserve important functions in the context of long-distance interactions mediated between locus control regions (LCRs) and their respective target promoters (12) (13) (14) .
MARs lack a unique sequence consensus. However, conserved sequence motifs and sequence compositions have been noted. These include origins of replication, A+T-rich sequences, topoisomerase II binding sites and topologically bent or kinked DNA (15) . A MarFinder algorithm has been assembled based on the integration of the frequency of these determinants in a defined sequence relative to the probability of their random occurrence in that sequence (MarFinder: http:// www.futuresoft.org/MAR-WIZ/). This algorithm has successfully predicted experimentally determined MARs at the β-globin, protamine, and apolipoprotein B loci (16) .
The human growth hormone gene cluster is composed of five structurally-related genes arranged in a common transcriptional orientation: 5′ hGH-N, hCS-L, hCS-A, hGH-V and hCS-B 3′ (Fig. 1A) . The 5′-most gene, hGH-N, is expressed exclusively in pituitary somatotropes while the remaining four genes are expressed in the syncytiotrophoblasts of the placenta (17) . Activation of the hGH gene cluster in both the pituitary and placenta is dependent on an LCR. The hGH LCR is comprised of five DNase I hypersensitive sites (HS) distributed from 15 to 32 kb 5′ of the hGH-N promoter (18, 19) (Fig. 1A) . The two closely linked and pituitary-specific HS, HSI and HSII, are both necessary and sufficient for high-level, positionindependent activation of hGH-N transgenes in mouse somatotropes (18, 20, 21) . Understanding how HSI,II activates the hGH promoter over a span of 15 kb is of central importance to defining the mechanisms of LCR action. In the current study, we test whether MAR element(s) are associated with the hGH LCR.
MATERIALS AND METHODS

Sequence analysis
The 1602 bp HSI,II sequence (GenBank accession no. AF039413) was analyzed using the Internet-based MarFinder algorithm (16) . A window size of 200 bp stepped at 10 bp intervals was used in the initial analysis. No sequence rules were omitted from the calculation. Sequence alignments were performed using MacVector software, version 6.5.1.
MAR assay
Cells were harvested from the pituitaries of multiple hGH/P1 transgenic adult mice as described previously (21) . HeLa cells were maintained at 37°C in 5% CO 2 in DMEM, containing 10% fetal bovine serum and 1% penicillin/streptomycin, prior to harvesting. Namalwa cells were maintained at 37°C in 5% CO 2 in RPMI 1640, containing 10% fetal bovine serum and 1% penicillin/streptomycin, prior to harvesting. The preparation of nuclear matrices under isotonic conditions was adapted from the procedure of Mirkovitch et al. (1) . Specifically, 10 7 cells were collected by centrifugation at 650 g for 5 min at 4°C and washed twice in 1 ml cold PBS. Cells were resuspended in 1 ml of 10 mM PIPES pH 7.8, 100 mM NaCl, 0.3 M sucrose, 3 mM MgCl 2 , 0.5% Triton X-100, and incubated on ice for 15 min until lysis occurred. Nuclei were collected by centrifugation at 1000 g for 5 min at 4°C, and washed twice with 1 ml cold PBS. Nuclei were gently resuspended in 100 µl PBS, and incubated at 37°C for 20 min to stabilize the nuclear scaffolds. One milliliter of 10 mM PIPES pH 7.0, 10 mM EDTA, 2 mM KCl, 0.25 mM spermidine, 0.1% w/v digitonin and 25 mM lithium 3,5-diiodosalicylic acid (LIS) was added dropwise while vortexing gently to extract histones. Nuclear halos were collected by centrifugation at 12 000 g for 10 min at 4°C, and washed five times with 1 ml of 50 mM Tris-HCl pH 7.9, 100 mM NaCl, 10 mM MgCl 2 , 1 mM DTT and 0.1% v/v aprotinin. Nuclear halos were resuspended in the same buffer including 400 U BglII (New England Biolabs), and incubated for 16 h at 37°C with gentle inversion. Soluble DNA (loop fraction) was separated from insoluble DNA (MAR fraction) by centrifugation at 12 000 g for 30 min at 4°C. The supernatant was removed to a separate tube, and the pellet was resuspended in 400 µl of the above restriction enzyme digestion buffer. Both fractions were treated with 0.1 g/l proteinase K in the presence of 1% SDS for 30 min at 37°C. Fractions were extracted with an equal volume of phenol, then with an equal volume of 25:24:1 phenol:chloroform:isoamyl alcohol. DNA was precipitated from the fractions with 1/10 vol 3 M sodium acetate and 2 vol absolute ethanol, washed with 70% ethanol and resuspended in 100 µl of 10 mM Tris pH 8.0 and 1 mM EDTA. DNA concentration was determined using a Hoefer DNA fluorometer and Hoechst 33258 dye (Sigma).
Five micrograms each of the MAR and loop fractions were resolved by electrophoresis in a 0.8% agarose gel in 40 mM Tris-acetate, 1 mM EDTA, pH 8.0 and visualized by staining in 5 µg/ml ethidium bromide. Resolved DNA was transferred to a positively-charged nylon membrane (Zetabind; Cuno Laboratory Products) by upward capillary transfer in 0.4 M NaOH using standard methods. Specific regions of DNA were detected by Southern hybridization to the nylon membrane using random-primed [α-32 P]dATP-labeled probes and standard procedures. All hybridizations were performed using the same blot; probe was stripped from the membranes between hybridizations by incubation with 0.2× SSC, 0.2% SDS at 95°C. Bands were visualized by autoradiography, and quantified by exposure of the hybridized blots to a storage phosphor screen with subsequent analysis by a Molecular Dynamics phosphorimager and ImageQuant software.
Nuclear halos were visualized by immobilizing nuclei from the cell lysis step onto glass slides in a cytocentrifuge (Shandon Cytospin 3) at 2000 r.p.m. for 5 min. Subsequent treatments to achieve nuclear halos were performed as above by applying the reagents directly to the slide. Nuclear halos were stained with 5 µg/ml Hoechst 33342 for 5 min, followed by a 5 min wash in dH 2 O prior to visualization by fluorescence microscopy at 1000×.
Probes employed to detect specific genomic regions
The human β-globin gene was detected with a cDNA probe encompassing the exon sequences from nucleotides 62279 to 63610, GenBank accession number U01317. The mouse immunoglobulin µ (Igµ) fragment containing the enhancerassociated MARs was detected with a probe encompassing nucleotides 3395-3681, GenBank accession number J00440. The position of probes used to detect regions of the human growth hormone locus are shown in Table 1 .
RESULTS
Prediction of a MAR associated with HSI,II
Previous studies have demonstrated that a 1.6 kb restriction fragment encompassing DNase I hypersensitive sites I and II (HSI,II) of the hGH LCR confers high-level and positionindependent expression upon a linked hGH-N transgene in the mouse pituitary (18, 20, 21) . HSI,II is naturally located 15 kb 5′ to the hGH-N transcription initiation site. Based on demonstrations of MAR-dependent LCR functions in other (16) . A peak of MAR potential was detected and considered to be highly significant on the basis of comparative studies (Fig. 1B) . The position of this peak adjacent to the major enhancer element of the hGH LCR (HSI,II) was remarkably similar to the positioning of functional MARs next to the major enhancer element of the Igµ LCR (4, 23) . These data suggested that HSI,II was associated with a MAR determinant.
Verification of the MAR assay
The cell-based detection of MARs involves the removal of histones and other non-histone proteins from chromatin by LIS extraction and subsequent identification of the DNA segments attached to the nuclear scaffold. After LIS extraction, the decondensed genomic DNA projects outward from the nuclear lamina network and forms a 'nuclear halo' (Fig. 2A) . Digestion of the halo preparation with a restriction enzyme solubilizes ∼70% of the DNA. This released DNA, the 'loop fraction', is considered to lack direct association with the nuclear matrix. The remaining 'MAR fraction' DNA can then be extracted from the sedimented DNA/protein complex. Equal masses of DNA purified from the loop and MAR fractions are analyzed by Southern blot using a series of unique sequence probes representing sites of interest. Restriction fragments containing sequences mediating scaffold association will be enriched in the MAR fraction, and their MAR:loop hybridization signal ratio will be >1.
HSI,II lacks MAR determinants in isolated nuclei
Most MARs appear to be constitutive (15) . This is true even for MARs associated with tissue-specific genes (24) . Thus, the initial search for a MAR associated with HSI,II was carried out in HeLa cells (Fig. 2B) . The data revealed that HSI,II sequences were enriched in the loop fraction. In contrast, the human β-globin gene in the same preparation was enriched in the MAR fraction at the 2-fold level, fully consistent with prior reports (14, 24) . Thus, HSI,II was not associated with MAR determinants in HeLa nuclei. It is possible that MAR activity associated with HSI,II might be limited to nuclei of cells expressing the hGH-N gene. Since there are no human somatotrope cell lines available for study, a transgenic mouse model for the human growth hormone locus was employed. This transgenic line carries an 87 kb P1 clone (hGH/P1) encompassing the entire hGH LCR and hGH gene cluster (Fig. 1A) . This hGH/P1 transgene fully recapitulates the normal human pattern of hGH-N expression (19) and LCR chromatin modification (25) in the mouse pituitary. HSI,II is formed in chromatin isolated from the pituitaries of these transgenic mice and the expression of the hGH-N gene is dependent on the presence of HSI,II function (Y.Ho, University of Pennsylvania, personal communication). Pituitaries from a representative hGH/P1 transgenic mouse line were isolated and a Southern blot of fractions from BglII-digested nuclear halos was prepared. As observed in HeLa cells, the 1.6 kb fragment containing HSI,II was enriched in the loop fraction (Fig. 2B) . The filter was stripped and rehybridized with a probe corresponding to the MARs associated with the mouse Igµ heavy chain LCR enhancer (4,23) as a positive control for this study. In full agreement with prior reports, this region was highly enriched in the MAR fraction (∼5-fold; Fig. 2B ). These data suggested that the HSI,II region was devoid of MAR determinants in expressing as well as non-expressing cells.
The hGH LCR and contiguous hGH gene cluster lack MARs
The initial analysis of MARs in the hGH LCR focused primarily on the region in close proximity to HSI,II. This was based on the dominant role of these sites in hGH LCR function and on the strong prediction of MAR potential by the MarFinder algorithm. The inability to detect MAR determinants adjacent to HSI,II by biochemical assay (Fig. 2B) suggested two possibilities: either the MARs that facilitate the long-range gene activation by HSI,II are located elsewhere in the hGH LCR, or hGH LCR-mediated activation was MAR independent. To distinguish between these two possibilities, the remaining regions of the hGH LCR and adjacent hGH gene cluster were probed for MARs (Fig. 3) . Since the full sequence and restriction map of this region is known (GenBank accession nos AC005803 and J03071), each of the contiguous fragments could be specifically probed. The data demonstrated that all regions tested were enriched in the loop fraction of the MAR preparation. This contrasted to the marked enrichment of Igµ intronic enhancer elements in the MAR fraction. Thus, the entire hGH LCR and hGH gene cluster was devoid of MAR determinants.
Sequences at HSI,II were introduced by a partial LINE-1 insertion in the primate lineage
In light of the detection of functional MARs by the MarFinder program in other systems (16) , it was of interest to determine the origin of the strong false-positive MAR prediction in the case of the hGH LCR. One possibility was that this region represented a MAR segment duplicated from elsewhere in the genome that had subsequently lost function. To determine whether sequences at HSI,II resembled any other known MAR-containing regions, we performed a BLAST search of existing human genomic DNA sequence databases (National Center for Biotechnology Information; http:// www.ncbi.nlm.nih.gov) with the 1.6 kb BglII fragment. Remarkably, this search resulted in 200 independent hits. The multiple genomic homology segments represented the unique L1PB2 subclass of LINE-1 elements. This subclass represents one of the earliest primate-specific LINE-1 elements. To delineate the relationship between this LINE and the putative MAR element, the HSI,II sequence was aligned directly to the deduced L1PB2 consensus sequence (26) . This alignment revealed a highly conserved LINE 3′-UTR with an AT-rich terminus (Fig. 4A) . Reanalysis of the HSI,II sequence with the MarFinder program using a narrower window (50 bp) localized the MAR potential peak precisely at the L1PB2 3′ A-rich tail (Fig. 4B) . Removal of this AT-rich segment from the sequence resulted in the loss of the MAR potential peak. Thus, the in silico HSI,II-linked MAR potential reflected the recent insertion of a 5′-truncated L1PB2 LINE element 5′ to the hGH gene cluster, and did not correlate with nuclear matrix association in a cell-based assay.
DISCUSSION
We have previously described a LCR located between 15 and 32 kb upstream of the hGH-N gene. The major determinant of hGH LCR action in the pituitary, HSI,II, has been mapped to a site 15 kb 5′ to the hGH-N gene promoter. HSI,II is sufficient for the high-level, position-independent, somatotrope-specific, and developmentally appropriate activation of the hGH-N transgene (18, 20, 21) . In the present study, we sought to determine whether the LCR-mediated long-range gene activation might be correlated with the presence of a MAR determinant(s) in this region. Using an algorithm based on the association of a set of putative sequence rules with known MARs, the region immediately encompassing HSI,II was predicted to contain MAR function (Fig. 1) . However, MAR assays of nuclei from HeLa cells and from primary pituitary cells failed to confirm MAR elements associated with HSI,II (Fig. 2) or with any other regions in the LCR or hGH gene cluster (Fig. 3) .
The role of MARs in the topological organization of the genome has suggested that they might have a role in transcriptional regulation. An emerging concept is that MARs organize the genome into discrete, autonomous regulatory domains. Studies in a number of systems support this model. The Drosophila melanogaster ftz, Sgs-4 (27), chicken lysozyme (28) , and human β-globin genes (29) are each flanked by MARs required for the insulation of transgenes from position effects (22, 30) . The prevalence of topoisomerase II sites at known MARs (4, 31) and evidence linking active chromatin and torsional stress in higher eukaryotes (32) (33) (34) suggests a mechanistic basis for such MAR-mediated functions. A number of MARs are also found in the proximity of transcriptional enhancers and may contribute to their ability to act over long distances. This enhancer facilitation may reflect sequestration of chromatin domains into specific subnuclear microenvironments and/or the regional modulation of chromatin accessibility. The most detailed evidence for the interaction of MARs with LCR elements and enhancers comes from studies of the intragenic mouse Igµ heavy chain LCR. The major enhancer element in this LCR is flanked by MARs (4, 23) . While these MARs have no appreciable effect on enhancer action in cell transfection studies (9, (35) (36) (37) , they have been found to markedly augment Igµ enhancer action in transgenic mouse B-cells. They extend the distance over which the Igµ enhancer can influence chromatin accessibility, core histone acetylation, DNA demethylation, and transcription (9, 11, 12) .
In contrast to the multiple studies documenting activity of MARs in gene expression, a number of studies indicate that these effects may not be universal (e.g. 38, reviewed in 39). For example, site-directed mutations of MARs flanking the murine β-globin gene (40) , the human Aγ-globin gene (41, 42) and the endogenous murine Igµ LCR (43) do not appear to alter expression of the associated promoters. Thus, the role of MARs may be specific to certain genes or particularly evident in specific experimental contexts.
The lack of MARs within the hGH LCR suggests that HSI,II activates the hGH-N transgene over an intervening distance of 15 kb by a MAR-independent mechanism. It has been established that this region of the LCR is a target for histone acetylation in a somatotrope nucleus (25) , possibly through recruitment of histone acetyltrasferase complexes by the POUhomeodomain factor Pit-1 (21, 44) . This recruitment triggers the modification of a 32 kb domain of chromatin acetylation extending 5′ to the most distal LCR determinant (HSV; -32 kb) and 3′ to the hGH-N promoter. This modification, targeted to HSI,II and subsequently spread throughout an extensive domain, may be sufficient to mediate hGH-N gene activation. Thus, the hGH LCR may utilize a mechanism of long-range gene activation that obviates the need for MAR function at this locus. 
